Medical devices, healthcare technology and the business of care
PMA approval · P230038

AbsorbaSeal 5.6.7F Vascular Closure Device

Cyndrx, LLC · Decision date Jun 5, 2026

FDA DECISIONP230038

What did the FDA approve?

FDA records P230038 as an original PMA application. The recorded decision is approval, dated Jun 5, 2026.

FDA approval order statement

the AbsorbaSeal 5.6.7F Vascular Closure Device. This device is indicated for use in percutaneous closure of femoral arterial access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures utilizing 5, 6, or 7F procedural sheaths.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 5, 2026

FDA source record

Regulatory record facts

Identifier
P230038
Regulatory pathway
Premarket approval application
Applicant
Cyndrx, LLC
Product code
MGB
Decision code
APPR
Decision date
Jun 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Applicant
Cyndrx, LLC
Product code
MGB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P230038 received

    Application receipt date recorded by FDA.

  2. P230038 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P230038. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cyndrx, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
205 Powell Pl., Suite 124, Brentwood, TN, 37027

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records